IL1B and Parkinson disease: This data is largely consistent with a previously reported study by Nagatsu et al. demonstrating an increase in various cytokines (TNF-α, IL-1β, IL-2, IL-4 and IL-6 in the striatum and cerebrospinal fluid of Parkinson’s disease patients [35].